Pharmacokinetics : The half-life was determined to be approximately six days, supporting once-weekly dosing
49,55,56,67 However, most of the clinical studies conducted up to date have focused on evaluating the effects of small molecule oral GLP-1 RAs against placebo
Compare with similar compounds The three compounds in the GLP-1-class spectrum (Semaglutide, Tirzepatide, Retatrutide) represent successive expansions of receptor coverage from one to two to three receptors
Retatrutide is investigational and not approved for human use
Over a thousand individuals, including medical professionals, celebrities, and the general public, have travelled from around the world to experience their weight-loss treatment
Night sweats are a type of vasomotor symptom characterized by excessive nighttime sweating